SCHEMBL1089209

SCHEMBL1089209

COc1cccc(CN2CC(Nc3nccc(N4CCCCCC4)n3)C2)c1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 2/20 0.55
KDM4E B2RXH2 4/20 0.45
ALDH1A1 P00352 2/20 0.45
TP53 P04637 2/20 0.45
MAPT P10636 2/20 0.45
MAPK1 P28482 2/20 0.45
HTT P42858 2/20 0.45
NPC1 O15118 1/20 0.45
ALOX15 P16050 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
BCHE P06276 2/20 0.44
ACHE P22303 2/20 0.44
BACE1 P56817 2/20 0.44
TSHR P16473 1/20 0.44
HRH4 Q9H3N8 3/20 0.43
IGF1R P08069 3/20 0.42
ALK Q9UM73 3/20 0.42
SYK P43405 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1089705 0.93 CXCR4 (0.58) CXCR4KDM4EALDH1A1TP53MAPT
SCHEMBL1090884 0.91 CXCR4 (0.60) CXCR4KDM4EALDH1A1MAPTMAPK1
SCHEMBL1089675 0.88 CXCR4 (0.58) CXCR4ACHEBACE1HRH4IGF1R
SCHEMBL1089124 0.85 CXCR4 (0.71) CXCR4KDM4EBCHEACHEBACE1
SCHEMBL1089498 0.85 CXCR4 (0.59) CXCR4ACHEBACE1HRH4IGF1R
SCHEMBL1090316 0.84 CXCR4 (0.56) CXCR4KDM4EALDH1A1MAPTHTT
SCHEMBL1088089 0.84 CXCR4 (0.64) CXCR4KDM4EHRH4IGF1RALK
SCHEMBL1092264 0.83 CXCR4 (0.52) CXCR4KDM4EMAPTMAPK1NPSR1
SCHEMBL1090532 0.83 CXCR4 (0.52) CXCR4KDM4EALDH1A1MAPTNPSR1
SCHEMBL1088981 0.83 CXCR4 (0.62) CXCR4BCHEACHEBACE1HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885KDM4E 2001/4885ALDH1A1 916/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 CXCR4 1/4885KDM4E 2001/4885ALDH1A1 916/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885KDM4E 2001/4885ALDH1A1 916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.